MedTrace Logo

Survival Monitoring in Russian Cancer Registries

NCT06043947 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2026-05-15

No results posted yet for this study

Summary

This study aims to establish a holistic framework for continuous cancer survival surveillance in Russian regions with high-quality population-based cancer registry data. The data from the population-based cancer registries of the Northwestern regions of Russia will be used to assess net and cause-specific survival trends.

Conditions

Sponsors & Collaborators

  • European University at St. Petersburg

    collaborator OTHER

  • N.N. Petrov National Medical Research Center of Oncology

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06043947 on ClinicalTrials.gov